Shares of Isis Pharmaceuticals Inc. rose 10 percent yesterday after the drug maker said it had received a milestone payment from Boehringer Ingelheim about its genetic treatment for Crohn's disease. The company, which is based in …
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it intends to offer, subject to market and other …
Intraday, BSX stock broke through some recent resistance at $13.75, before closing out the day at $13.81. The agreement states that JNJ will pay ISIS up to $835 million to allow Janssen the option to license three of these drugs for …
Ionis’ decision is understandable, especially given the publicly-traded company appears as “ISIS” on stock exchange tickers; not exactly an attractive target for potential investors. “Our goal is to create medicines that will save patients’ …
The Telegraph also reported the hearing was told top ISIS leaders were playing the stock markets. David Butter, an …
One stock that might be an intriguing choice for investors right now is Isis Pharmaceuticals, Inc. ( ISIS). This is because this security in the Med-Biomed/Generic industry space is seeing solid earnings estimate revision activity, and is in …
ISIS is defeated. There's a lot of good things that have been ... MULVANEY: It's 25 and I think we do half of that this year and half of that next year. WALLACE: The …
Unlike an IPO, which gives investors stock ownership in a company ... Edward …
History will mark down 2014 as the year predicted 49 years ago by Martha and the Vandellas. In 1965 the group recorded a Motown classic, “Nowhere to Run, Nowhere to Hide.” We’re there, at the brink. Liberia, ISIS, Ukraine, Hong Kong, a …
Cruz wasn’t a Muslim or a member of ISIS but a home-grown terrorist with this weapon that ... will do nothing to stop this carnage. The bump stock that helped the shooter in Las Vegas to kill so many could have been outlawed but wasn’t.